Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Arinola Dada (NPI 1609871029)

Field	Value
Entity Type	Individual
Organization	Arinola Dada
Address	1310 116th Ave Ne
City	Bellevue
State	WA
ZIP	98004
Taxonomy	Rheumatology Physician
NPI Enumerated	June 14, 2005

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-focused practice with lifetime Medicare revenue of $1.6M and no Medicaid billing on file; the absence of Medicaid activity makes the provider a single‑payer (Medicare) operation for the dataset shown. That payer concentration should be considered when evaluating reimbursement risk or network-value to Medicaid-managed plans.

Revenue is highly concentrated in a small set of biologic drug codes: the precomputed top 3 Medicare codes by revenue account for 50.9% of this provider's total Medicare revenue. Those top codes are J1602 ($289.9K, 17.5%), J0129 ($279.7K, 16.9%), and J0897 ($271.1K, 16.4%), indicating that roughly half of Medicare dollars flow through three injectable biologic agents.

The CPT/HCPCS mix points to a rheumatology practice with an infusion/administration component: multiple high-revenue J‑codes for biologic agents (J1602, J0129, J0897, J1745, J0717, J3111) alongside infusion/administration codes such as 96365 and J7050. This pattern is consistent with a clinic that both manages chronic autoimmune disease and provides on-site drug administration rather than relying solely on self-injectable therapies.

Competitive standing is mixed across drugs: J0897 ranks #535 of 10057 providers nationally (95th percentile; notably above typical national volume), marking this provider as a substantial national outlier for denosumab administration, while J1602 (rank #194 of 1041, 81th percentile; typical) and J0129 (rank #584 of 1221, 52th percentile; typical) are in more typical volume bands. In short, the practice is a modest-to-typical participant for several biologics but a notably high-volume administrator of J0897.

Office visit activity is an important revenue stream: 99214 generated $137.9K (8.3% of Medicare revenue) and the provider’s 99214 usage is an extreme outlier (ranks #5315 of 479517 providers nationally, 99th percentile; extreme outlier, far above typical national volume). This suggests a sizeable established-patient panel and substantial visit-based management in addition to infusion services.

Support services and infusion throughput are evidenced by above-typical ranks on administration codes: 96365 (356 claims, ranks #727 of 8873, 92th percentile; typical) and J7050 (589 claims, ranks #168 of 1837, 91th percentile; typical), while 96372 (690 claims) is at the 98th percentile (notably above typical national volume). Those ranks imply a clinic workflow and staffing model able to handle frequent injections and intravenous administrations.

The practice’s service mix includes osteoporosis-focused care in addition to rheumatology: J3111 (romosozumab, $196.6K, 11.9% of Medicare revenue) and J0897 (denosumab) together with 77080 (DXA, $11.5K, 0.7% of Medicare revenue, ranks #2883 of 17308, 83th percentile; typical) indicate both pharmacologic osteoporosis treatment and routine bone-density monitoring. This combination suggests coordinated longitudinal bone-health management as a meaningful component of clinical activity.

The provider has a long tenure on file (NPI enumerated 2005-06-14, approximately 21 years ago), which supports the observed established-patient volume and could explain sustained infusion and administration activity. Given the lack of Medicaid billing, analysts should treat this entity as a long-standing Medicare-participating rheumatology/infusion clinic when assessing market position or partnership opportunities.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

26 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1602	Injection, golimumab, 1 mg, for intravenous use	26,350	$10	$289.9K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	8,480	$30	$279.7K
J0897	Injection, denosumab, 1 mg	15,060	$20	$271.1K
J3111	Injection, romosozumab-aqqg, 1 mg	24,570	$10	$196.6K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	47,200	$1	$188.8K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,030	$30	$156.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,330	$100	$137.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	240	$120	$28.8K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	360	$60	$19.9K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	130	$150	$19.2K

Showing 1–10 of 26

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 26 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Arinola Dada — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

26 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	6	20	5,280	$30	$208.7K
J0717	2	10	38,800	$1	$140.5K
J1602	4	20	7,060	$10	$135.2K
J1745	10	50	3,630	$30	$111.5K
J3111	1	10	8,820	$10	$99.4K
J0897	3	150	1,800	$20	$57.9K
96413	28	160	80	$110	$15K
99214	58	10,860	100	$80	$13.6K
99215	579	4,320	40	$120	$8.4K
99213	4,162	9,690	60	$60	$6.5K

Showing 1–10 of 26

Related Providers

Other providers that share a Tax Identification Number (TIN) with Arinola Dada, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kent Ta	WA	Rheumatology Physician	$1.1M	$0
Jeffrey Mathews	UT	Rheumatology Physician	$61.9K	$0

Nearby Providers

Other providers in the same ZIP code as Arinola Dada, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Universal Language Service, Inc.	WA	Contractor	$0	$103.7M
Overlake Medical Center & Clinics	WA	General Acute Care Hospital	$0	$16.6M
Daiya Healthcare PLLC	WA	Internal Medicine Physician	$0	$8.7M
Steve Kim	WA	Ophthalmology Physician	$3.4M	$20
David Saperstein	WA	Ophthalmology Physician	$3.3M	$100
Andrew Barloon	WA	Ophthalmology Physician	$2.7M	$20
Puget Sound Physicians PLLC	WA	Emergency Medicine Physician	$0	$2.5M
Northwest Kidney Centers	WA	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$2.5M
Charles Birnbach	WA	Ophthalmology Physician	$2.4M	$0
Todd Klesert	WA	Ophthalmology Physician	$2.1M	$0

Arinola Dada — Billing Profile & Reimbursement Data

Sign up for Arinola Dada — Billing Profile & Reimbursement Data policy alerts

Arinola Dada — Billing Profile & Reimbursement Data

Sign up for Arinola Dada — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References